Overexpression of Sra-1Scer\UAS.cSa under the control of Scer\GAL4elav-C155 does not result in any defects in the overall morphology of the embryonic nervous system.
CyfipUAS.cSa, Scer\GAL4P2.4.Pdf is a non-suppressor of abnormal neuroanatomy phenotype of Fmr1E68K.EP3517, Scer\GAL4P2.4.Pdf
CyfipUAS.cSa, Fmr1E68K.EP3517, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype
CyfipUAS.cSa, Fmr1R115H.EP3517, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype
CyfipUAS.cSa, Fmr1S174F.EP3517, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype
CyfipUAS.cSa, Scer\GAL4P2.4.Pdf is a non-suppressor of LNv neuron phenotype of Fmr1E68K.EP3517, Scer\GAL4P2.4.Pdf
CyfipUAS.cSa, Fmr1E68K.EP3517, Scer\GAL4elav.PU has neuromuscular junction phenotype
CyfipUAS.cSa, Fmr1R115H.EP3517, Scer\GAL4elav.PU has neuromuscular junction phenotype
CyfipUAS.cSa, Fmr1S174F.EP3517, Scer\GAL4elav.PU has neuromuscular junction phenotype
Co-expression of Sra-1Scer\UAS.cSa does not suppress the defasciculation of LNv neurons caused by Scer\GAL4P2.4.Pdf; Fmr1E68K.EP3517
Co-overexpression of Fmr1E68K.EP3517 and Sra-1Scer\UAS.cSa using Scer\GAL4elav.PU results in a significant neuromuscular junction overgrowth phenotype.
Co-overexpression of Fmr1R115H.EP3517 and Sra-1Scer\UAS.cSa using Scer\GAL4elav.PU results in a significant neuromuscular junction overgrowth phenotype.
Co-overexpression of Fmr1S174F.EP3517 and Sra-1Scer\UAS.cSa using Scer\GAL4elav.PU results in a significant neuromuscular junction overgrowth phenotype.
The reduced synaptic length seen at the neuromuscular junction of Sra-185.1 larvae is rescued by expression of Sra-1Scer\UAS.cSa under the control of Scer\GAL4elav-C155.
Rescues the midline crossing phenotype seen by longitudinal connectives and the early pupal lethality, in Sra-185.1 mutants. This rescue is dose dependant, improving with more copies of P{UAS-CYFIP.S}.